As some of you know, my cat has been diagnosed as diabetic and requires insulin injection. He was prescribed Lantus, which is a long-acting insulin called “glargine insulin” that slowly infiltrates the body from the injection site during the course of the day rather than hitting in one big insulin hit. This is sort of the Gold Standard of insulin, controlling blood sugar far better than anything other than an insulin pump. Sometimes you can bring a cat with Type 2 diabetes back to non-insulin-dependent status by using this stuff to regulate his blood sugar until his body readjusts to operating with normal level blood sugar. Tapering off then lets his pancreas take over insulin production again and you have your cat back, albeit with severe dietary restrictions to keep his weight and blood sugar down. Yeah, that doesn’t really happen with people, but cats are weird.
TMF probably isn’t going to be in that cat-egory because his blood sugar was so high, but my vet said it was worth trying. my vet said “Okay, it’s expensive, but this is the gold standard and a $180 vial will last you several months.”
Well, it was a $180 vial in 2014, the year before its patent expired. Today it’s a $290 vial.
What happened? Competition happened. Two competitors entered the market, releasing two competing products, Basaglar and Toujeo. So, what happened? Why did prices go up rather than down the way the free market maniacs are always claiming competition will do in healthcare?!
Well: The maker of Lantus has a fixed amount of profit they want to make from Lantus. If volume goes down — which happened with competition — then they raise the price to make that amount of profit. And the competitors have similar price desires, so try to compete based on something other than price –Toujeo is more concentrated than Lantus (more doses per milliliter). Or if they’re wanting to compete on price, they price 10% below the market leader, because that’s what maximizes their profit (see: Basaglar). Every time Lantus raises their price to meet their profit goals, the other two raise their prices in lockstep to maximize their *own* profits.
So competition nearly doubled the price of my cat’s insulin within three years.
So much for that healthcare “reform” nonsense about “competition reduces prices!”. It just doesn’t seem to work that way in the real world, at least not for healthcare.
– Badtux the “Free Market Orthodoxy is religion, not fact” Penguin